Table 5 Multivariate analysis of DFS and known prognostic factors in stage II-III colon carcinoma patients.

From: Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer

Parameters

No. at riska

Events

HR

95% CI

p value

HR

95% CI

p value

Sex

    

0.24

  

0.26

  Female

401

133

1.00

  

1.00

  

  Male

466

166

1.15

0.91–1.45

 

1.14

0.91–1.44

 

Age

    

<0.0001*

  

<0.0001*

  <65

387

103

1.00

  

1.00

  

  ≥65

480

195

1.64

1.29–2.08

 

1.68

1.32–2.13

 

pT stage

    

0.009

  

0.007

  T1-2

32

5

1.00

  

1.00

  

  T3-4

833

227

3.26

1.34–7.94

 

3.39

1.39–8.26

 

pN stage

    

<0.0001*

  

<0.0001*

  Negative

457

125

1.00

  

1.00

  

  Positive

410

173

1.83

1.45–2.31

 

1.90

1.50–2.40

 

Tumor location

    

0.04

  

0.06

  Proximal colon

425

157

1.00

  

1.00

  

  Distal colon

442

141

0.78

0.62–0.98

 

0.81

0.64–1.01

 

CD8+ TILs

    

<0.0001

   

  High

283

60

1.00

     

  Low

584

238

1.86

1.40–2.49

 

 

Tumor CD274(PD-L1)

    

0.009

   

  High

384

108

1.00

     

  Low

480

190

1.37

1.08–1.74

 

 

CD8+ TILs and tumor CD274(PD-L1)

       

<0.0001

  High or high

507

137

   

1.00

  

  Low/Low

360

161

 

1.77

1.41–2.22

 
  1. aNumber of cases may differ due to missing data. *p < 0.005 is significant and 0.005 < p < 0.05 is suggestive evidence.